Imatinib improves but may not fully reverse the poor prognosis of patients with CML with derivative chromosome 9 deletions.
暂无分享,去创建一个
A. Green | R. Clark | G. Vassiliou | M. Deininger | D. Niederwieser | B. Huntly | F. Guilhot | A. Reid | N. Bown | E. Nacheva | A. Brizard | E. Hennig | C. Franke | J. Byrne | Julie Freeman-Edward | G. Cuthbert